Applications
Morphine and Metabolites on Synergi Polar-RP (direct injection after PPT)
16446
Separation Mode: Reversed Phase
Reversed Phase
Polar-RP
HPLC
Central Nervous System Stimulants
Pharmaceutical
Therapeutic / Clinical

Applications

Morphine and Metabolites on Synergi Polar-RP (direct injection after PPT)

Analytes

1
2
3
Compound Name
Morphine
CID
5288826
Molecular Formula
C17H19NO3
Molecular Weight
285
No. Hydrogen Bond Acceptors
4
No. Hydrogen Bond Donors
2

Conditions

LC Conditions (App ID: 16446)
Column:Synergi 4 µm Polar-RP 80 Å, LC Column 100 x 2 mm, Ea
Brand Name:Synergi
Part No:00D-4336-B0
Elution Type:Gradient
Mobile Phase:A: 0.1% Formic Acid in Water
B: 0.1% Formic Acid in Acetonitrile
Gradient Profile:
Step No.Time(min)%A%B
10973
22973
34.85050
Flow Rate:0.4 mL/min
Temperature:22°C
Detection:Mass Spectrometer (MS) amu @ 22°C

Order Items Used in This Application

Similar Applications
No Data